Raymond James & Associates’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-33
Closed -$4K 3624
2018
Q3
$4K Sell
33
-2
-6% -$5.22K ﹤0.01% 3607
2018
Q2
$96K Sell
35
-57
-62% -$132K ﹤0.01% 3406
2018
Q1
$249K Buy
92
+24
+35% +$55.1K ﹤0.01% 3006
2017
Q4
$161K Sell
68
-49
-42% -$108K ﹤0.01% 3123
2017
Q3
$236K Sell
117
-44
-27% -$57.4K ﹤0.01% 2941
2017
Q2
$186K Buy
161
+60
+59% +$80.1K ﹤0.01% 3006
2017
Q1
$161K Buy
101
+70
+226% +$128K ﹤0.01% 2982
2016
Q4
$53K Sell
31
-6
-16% -$13.1K ﹤0.01% 3093
2016
Q3
$90K Hold
37
﹤0.01% 3015
2016
Q2
$92K Sell
37
-1
-3% -$3.29K ﹤0.01% 2817
2016
Q1
$136K Buy
+38
New +$132K ﹤0.01% 2666
2015
Q3
Sell
-40
Closed -$335K 2333
2015
Q2
$335K Buy
40
+3
+8% +$28.6K ﹤0.01% 2246
2015
Q1
$366K Buy
+37
New +$340K ﹤0.01% 2150

Other funds holding IMUX